Literature DB >> 8317769

Pharmacokinetics of propofol in mixed-breed dogs and greyhounds.

D L Zoran1, D H Riedesel, D C Dyer.   

Abstract

Pharmacokinetics and recovery characteristics of propofol in Greyhounds and mixed-breed dogs were compared. In all dogs, disposition of propofol was adequately described by a 2-compartment open model, with a rapid distribution phase followed by a slower elimination phase. When findings in Greyhounds were compared with those in mixed-breed dogs, significant differences were observed in mean concentrations of propofol in blood, recovery characteristics, and estimates for apparent volume of distribution, volume of distribution at steady state, and total body clearance. In addition, Greyhounds recovered from anesthesia at higher concentrations of propofol than did mixed-breed dogs. A secondary peak in blood propofol concentration was observed in 8 of 10 Greyhounds and in 5 of 8 mixed-breed dogs. This peak corresponded to the time of return of the righting reflex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317769

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  13 in total

Review 1.  Factors influencing the bioavailability of peroral formulations of drugs for dogs.

Authors:  S Sabnis
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

2.  Anesthetic properties of a propofol microemulsion in dogs.

Authors:  Timothy E Morey; Jerome H Modell; Dushyant Shekhawat; Dinesh O Shah; Brian Klatt; George P Thomas; Frank A Kero; Matthew M Booth; Donn M Dennis
Journal:  Anesth Analg       Date:  2006-10       Impact factor: 5.108

3.  Pharmacokinetics of oral terbinafine in horses and Greyhound dogs.

Authors:  M M Williams; E G Davis; B KuKanich
Journal:  J Vet Pharmacol Ther       Date:  2011-06       Impact factor: 1.786

4.  Thromboelastographic and pharmacokinetic profiles of micro- and macro-emulsions of propofol in swine.

Authors:  Timothy E Morey; Jerome H Modell; Jorge E Garcia; Michael Bewernitz; Hartmut Derendorf; Manoj Varshney; Nikolaus Gravenstein; Dinesh O Shah; Donn M Dennis
Journal:  Biopharm Drug Dispos       Date:  2010-07       Impact factor: 1.627

5.  Propofol or thiopentone as induction agents in romifidine-sedated and halothane-N2O-anesthetized dogs: a preliminary study.

Authors:  J I Redondo; R J Gómez-Villamandos; J M Domínguez; J M Santisteban
Journal:  Can J Vet Res       Date:  2000-10       Impact factor: 1.310

6.  Pharmacokinetics of the cytochrome P-450 substrates phenytoin, theophylline, and diazepam in healthy Greyhound dogs.

Authors:  B KuKanich; J L Nauss
Journal:  J Vet Pharmacol Ther       Date:  2011-06-22       Impact factor: 1.786

Review 7.  Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model.

Authors:  Steven Fleischer; Michele Sharkey; Katrina Mealey; Elaine A Ostrander; Marilyn Martinez
Journal:  AAPS J       Date:  2008-02-15       Impact factor: 4.009

8.  Canine cytochrome P-450 pharmacogenetics.

Authors:  Michael H Court
Journal:  Vet Clin North Am Small Anim Pract       Date:  2013-06-13       Impact factor: 2.093

9.  Romifidine, medetomidine or xylazine before propofol-halothane-N2O anesthesia in dogs.

Authors:  J I Redondo; R J Gómez-Villamandos; J M Santisteban; J M Domínguez; I Ruiz; I Avila
Journal:  Can J Vet Res       Date:  1999-01       Impact factor: 1.310

10.  Evaluation of efficacy and safety of glycopyrrolate - xylazine - propofol anesthesia in buffalo calves.

Authors:  Sandeep Potliya; Ashok Kumar; Sandeep Kumar; Sukhbir Singh; Sarvan Kumar
Journal:  Vet World       Date:  2015-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.